Advertisement

Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II

      Abstract

      Lin-28 and lin-28B are RNA-binding proteins which can block microRNA let-7 maturation and affect the differentiation and proliferation of embryonic stem cells. Lin-28 may also regulate the expression of insulin-like growth factor II (IGF-II). As one of the pluripotent factors involved in making induced pluripotent stem cells (iPS), lin-28 is considered a potential therapeutic target for cancer treatment. To further understand the role of lin-28 in cancer, we analysed the expression of lin-28 and its homologue lin-28B in tumour samples, and evaluated their associations with let-7a maturation, IGF-II expression, disease features and outcomes in 211 patients with primary epithelial ovarian cancer. The analysis showed that both lin-28 and lin-28B were positively correlated with primary and pre-let-7a-3; lin-28B, not lin-28, was inversely correlated with mature let-7a. A positive correlation was also observed between lin-28B and IGF-II expression, while no association was found between lin-28B and IGF-I or IGFBP-3. The study further demonstrated that lin-28B expression was associated with the risk of disease progression and death; patients with high lin-28B had shorter progression-free and overall survival than those with low lin-28B. These results seem to support the findings of recent in vitro experiments, showing that lin-28 blocks the process of let-7a maturation. Our study also suggests that lin-28B may promote ovarian cancer progression and serve as an unfavourable prognostic marker for the disease. The correlation between lin-28B and IGF-II indicates that the growth factor may mediate the effect of lin-28B on tumour growth.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Reinhart B.J.
        • Slack F.J.
        • Basson M.
        • et al.
        The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.
        Nature. 2000; 403: 901-906
        • Johnson C.D.
        • Esquela-Kerscher A.
        • Stefani G.
        • et al.
        The let-7 microRNA represses cell proliferation pathways in human cells.
        Cancer Res. 2007; 67: 7713-7722
        • Selbach M.
        • Schwanhausser B.
        • Thierfelder N.
        • et al.
        Widespread changes in protein synthesis induced by microRNAs.
        Nature. 2008; 455: 58-63
        • Mayr C.
        • Hemann M.T.
        • Bartel D.P.
        Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.
        Science. 2007; 315: 1576-1579
        • Park S.M.
        • Shell S.
        • Radjabi A.R.
        • et al.
        Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.
        Cell Cycle. 2007; 6: 2585-2590
        • Yu F.
        • Yao H.
        • Zhu P.
        • et al.
        Let-7 regulates self renewal and tumorigenicity of breast cancer cells.
        Cell. 2007; 131: 1109-1123
        • Akao Y.
        • Nakagawa Y.
        • Naoe T.
        Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
        Biol Pharm Bull. 2006; 29: 903-906
        • Takamizawa J.
        • Konishi H.
        • Yanagisawa K.
        • et al.
        Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
        Cancer Res. 2004; 64: 3753-3756
        • Shell S.
        • Park S.M.
        • Radjabi A.R.
        • et al.
        Let-7 expression defines two differentiation stages of cancer.
        Proc Natl Acad Sci USA. 2007; 104: 11400-11405
        • Kumar M.S.
        • Erkeland S.J.
        • Pester R.E.
        • et al.
        Suppression of non-small cell lung tumor development by the let-7 microRNA family.
        Proc Natl Acad Sci USA. 2008; 105: 3903-3908
        • Brueckner B.
        • Stresemann C.
        • Kuner R.
        • et al.
        The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
        Cancer Res. 2007; 67: 1419-1423
        • Viswanathan S.R.
        • Daley G.Q.
        • Gregory R.I.
        Selective blockade of microRNA processing by Lin28.
        Science. 2008; 320: 97-100
        • Newman M.A.
        • Thomson J.M.
        • Hammond S.M.
        Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing.
        RNA. 2008; 14: 1539-1549
        • Piskounova E.
        • Viswanathan S.R.
        • Janas M.
        • et al.
        Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28.
        J Biol Chem. 2008; 283: 21310-21314
        • Lu L.
        • Katsaros D.
        • de la Longrais I.A.
        • Sochirca O.
        • Yu H.
        Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
        Cancer Res. 2007; 67: 10117-10122
        • Yu J.
        • Vodyanik M.A.
        • Smuga-Otto K.
        • et al.
        Induced pluripotent stem cell lines derived from human somatic cells.
        Science. 2007; 318: 1917-1920
        • Moss E.G.
        • Lee R.C.
        • Ambros V.
        The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA.
        Cell. 1997; 88: 637-646
        • Yang D.H.
        • Moss E.G.
        Temporally regulated expression of lin-28 in diverse tissues of the developing mouse.
        Gene Exp Patterns. 2003; 3: 719-726
        • Guo Y.
        • Chen Y.
        • Ito H.
        • et al.
        Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.
        Gene. 2006; 384: 51-61
        • Polesskaya A.
        • Cuvellier S.
        • Naguibneva I.
        • et al.
        Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency.
        Genes Dev. 2007; 21: 1125-1138
        • Lu L.
        • Katsaros D.
        • Wiley A.
        • et al.
        The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
        Clin Cancer Res. 2006; 12: 1208-1214
        • Lu L.
        • Katsaros D.
        • Wiley A.
        • et al.
        Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
        Gynecol Oncol. 2006; 103: 990-995
        • Guvakova M.A.
        Insulin-like growth factors control cell migration in health and disease.
        Int J Biochem Cell Biol. 2007; 39: 890-909
        • Beeghly A.
        • Katsaros D.
        • Chen H.
        • et al.
        Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.
        Gynecol Oncol. 2006; 100: 330-337
        • Brokaw J.
        • Katsaros D.
        • Wiley A.
        • et al.
        IGF-I in epithelial ovarian cancer and its role in disease progression.
        Growth Factors. 2007; 25: 346-354
      1. Gee HE, Camps C, Buffa FM, et al. MicroRNA-10b and breast cancer metastasis. Nature 2008;455:E8–9 [author reply E9].

        • Wiley A.
        • Katsaros D.
        • Fracchioli S.
        • Yu H.
        Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer.
        Int J Gynecol Cancer. 2006; 16: 210-218
        • Heo I.
        • Joo C.
        • Cho J.
        • et al.
        Lin28 mediates the terminal uridylation of let-7 precursor microRNA.
        Mol Cell. 2008; 32: 276-284
        • Rybak A.
        • Fuchs H.
        • Smirnova L.
        • et al.
        A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment.
        Nat Cell Biol. 2008; 10: 987-993
        • Vasudevan S.
        • Tong Y.
        • Steitz J.A.
        Switching from repression to activation: microRNAs can up-regulate translation.
        Science. 2007; 318: 1931-1934
        • Sampath P.
        • Pritchard D.K.
        • Pabon L.
        • et al.
        A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation.
        Cell Stem Cell. 2008; 2: 448-460
        • Balzer E.
        • Moss E.G.
        Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules.
        RNA Biol. 2007; 4: 16-25
        • Liu T.
        • Zimmerman K.K.
        • Patterson G.I.
        Regulation of signaling genes by TGFbeta during entry into dauer diapause in C. elegans.
        BMC Dev Biol. 2004; 4: 11
        • Kumar M.S.
        • Lu J.
        • Mercer K.L.
        • Golub T.R.
        • Jacks T.
        Impaired microRNA processing enhances cellular transformation and tumorigenesis.
        Nat Genet. 2007; 39: 673-677
        • Chang T.C.
        • Zeitels L.R.
        • Hwang H.W.
        • et al.
        Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation.
        Proc Natl Acad Sci USA. 2009; 106: 3384-3389